Literature DB >> 21145922

eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.

Brynhildur Thors1, Haraldur Halldórsson, Gudmundur Thorgeirsson.   

Abstract

Reports on the role of AMP-activated protein kinase (AMPK) in thrombin-mediated activation of endothelial nitric-oxide synthase (eNOS) in endothelial cells have been conflicting. Previously, we have shown that under culture conditions that allow reduction of ATP-levels after stimulation, activation of AMPK contributes to eNOS phosphorylation and activation in endothelial cells after treatment with thrombin. In this paper we examined the signaling pathways mediating phosphorylation and activation of eNOS after stimulation of cultured human umbilical vein endothelial cells (HUVEC) with histamine and the role of LKB1-AMPK in the signaling. In Morgan's medium 199 intracellular ATP was lowered by treatment with histamine or the ionophore A23187 while in medium RMPI 1640 ATP was unchanged after identical treatment. In medium 199 inhibition of Ca(+2)/CaM kinase kinase (CaMKK) by STO-609 only partially inhibited AMPK phosphorylation but after gene silencing of LKB1 with siRNA there was a total inhibition of AMPK phosphorylation by STO-609 after treatment with either histamine or thrombin, demonstrating phosphorylation of AMPK by both upstream kinases, LKB1 and CaMKK. Downregulation of AMPK with siRNA partially inhibited eNOS phosphorylation caused by histamine in cells maintained in medium 199. Downregulation of LKB1 by siRNA inhibited both phosphorylation and activity of eNOS and addition of the AMPK inhibitor Compound C had no further effect on eNOS phosphorylation. When experiments were carried out in medium 1640, STO-609 totally prevented the phosphorylation of AMPK without affecting eNOS phosphorylation. AMPKα2 downregulation resulted in a loss of the integrity of the endothelial monolayer and increased expression of GRP78, indicative of endoplasmic reticular (ER) stress. Downregulation of AMPKα1 had no such effect. The results show that culture conditions affect endothelial signal transduction pathways after histamine stimulation. Under conditions where intracellular ATP is lowered by histamine, AMPK is activated by both LKB1 and CaMKK and, in turn, mediates eNOS phosphorylation in an LKB1 dependent manner. Both AMPKα1 and -α2 are involved in the signaling. Under conditions where intracellular ATP is unchanged after histamine treatment, CaMKK alone activates AMPK and eNOS is phosphorylated and activated independent of AMPK. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145922     DOI: 10.1016/j.bbamcr.2010.12.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Growth inhibition of human gastric adenocarcinoma cells in vitro by STO-609 is independent of calcium/calmodulin-dependent protein kinase kinase-beta and adenosine monophosphate-activated protein kinase.

Authors:  Zhiming Ma; Dacheng Wen; Xudong Wang; Longfei Yang; Tianzhou Liu; Jingjing Liu; Jiaming Zhu; Xuedong Fang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Store-operated Ca2+ entry (SOCE) induced by protease-activated receptor-1 mediates STIM1 protein phosphorylation to inhibit SOCE in endothelial cells through AMP-activated protein kinase and p38β mitogen-activated protein kinase.

Authors:  Premanand C Sundivakkam; Viswanathan Natarajan; Asrar B Malik; Chinnaswamy Tiruppathi
Journal:  J Biol Chem       Date:  2013-04-26       Impact factor: 5.157

3.  Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation injury through AMPK/eNOS/PGC-1α signaling pathway.

Authors:  Liang Hu; Lu Zhou; Xiaowei Wu; Chao Liu; Yue Fan; Qingping Li
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of RhoA signaling.

Authors:  Zhenquan Jia; Wei Zhen; Pon Velayutham Anandh Babu; Dongmin Liu
Journal:  Endocrinology       Date:  2012-12-18       Impact factor: 4.736

5.  Advantages and pitfalls of combining intravenous antithrombin with nebulized heparin and tissue plasminogen activator in acute respiratory distress syndrome.

Authors:  Sebastian Rehberg; Yusuke Yamamoto; Linda E Sousse; Collette Jonkam; Robert A Cox; Donald S Prough; Perenlei Enkhbaatar
Journal:  J Trauma Acute Care Surg       Date:  2014-01       Impact factor: 3.313

6.  High-glucose treatment regulates biological functions of human umbilical vein endothelial cells via Sirt1/FOXO3 pathway.

Authors:  Yihui Chen; Yan Wang; Yaping Jiang; Xiaoyan Zhang; Minjie Sheng
Journal:  Ann Transl Med       Date:  2019-05

7.  Roles of KLF4 and AMPK in the inhibition of glycolysis by pulsatile shear stress in endothelial cells.

Authors:  Yue Han; Ming He; Traci Marin; Hui Shen; Wei-Ting Wang; Tzong-Yi Lee; Hsiao-Chin Hong; Zong-Lai Jiang; Theodore Garland; John Y-J Shyy; Brendan Gongol; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

8.  Green tea extract increases mRNA expression of enzymes which influence epigenetic marks in newborn female offspring from undernourished pregnant mother.

Authors:  Yongkun Sun; Yuuka Mukai; Masato Tanaka; Takeshi Saito; Shin Sato; Masaaki Kurasaki
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

9.  Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation.

Authors:  Cristina Gallo; Katiuscia Dallaglio; Barbara Bassani; Teresa Rossi; Armando Rossello; Douglas M Noonan; Gabriele D'Uva; Antonino Bruno; Adriana Albini
Journal:  Oncotarget       Date:  2016-09-13

10.  Association between STK11 Gene Polymorphisms and Coronary Artery Disease in Type 2 Diabetes in Han Population in China.

Authors:  Xiaowei Ma; Ge Bai; Difei Lu; Linjuan Huang; Jianwei Zhang; Ruifen Deng; Shan Ding; Nan Gu; Xiaohui Guo
Journal:  J Diabetes Res       Date:  2017-02-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.